Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2017–2022 · cooperative agreement · U01
Development of Risk and Early Detection Biomarker for Small Cell Lung Cancer
Samir M Hanash · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2018 · research · R35
In vivo genetic engineering of T-cells for treatment of human diseases
Sherry Wu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · cooperative agreement · U24
Pancreatic Ductal Adenocarcinoma Translational Resource Center (PATReC)
Anirban Maitra · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Significance of Inhibiting Long Non-coding RNAs in Advanced Breast Cancer
Chunru Lin · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Uncovering the Role of Colorectal Stem Cells on Disease Penetrance in Lynch Syndrome
Eduardo Vilar Sanchez · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · cooperative agreement · U54
Evaluating drug combinations, efficacy and adaptive feedback in KRAS inhibition
Funda Meric-Bernstam · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · program · P40
Specific Pathogen Free Baboon Research Resource (SPFBRR)
Christian R Abee · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2021 · research · R01
Role of response regulator phosphorylation in group A streptococcal pathogenesis
Samuel A Shelburne · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2024 · research · R01
Wnt/?-catenin Signaling in Pancreatic Oncogenesis
Anirban Maitra · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2025 · research · R01
Multi-Site Development & Evaluation of a Quantitative 3D Hyperpolarized C-13 MRI Clinical Prostate Cancer Exam
James A Bankson · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · program · P40
Specific Pathogen Free Baboon Research Resource (SPFBRR)
Joe H. Simmons · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Inhibition of brain metastasis by blocking MAPK12 driver kinase functions
Dihua Yu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · program · P50
U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer
Robert C Bast · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2019 · research · R03
A Novel Mouse Model for Uterine Leiomyoma
Kwong Kwok Wong · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Wnt/?-catenin Signaling in Pancreatic Oncogenesis
Anirban Maitra · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2024 · research · R35
Harnessing the power of exosomes for non-coding RNA delivery
Anil K Sood · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
The roles of TRIM24 in breast cancer
Guillermina Lozano · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · program · P40
Specific Pathogen Free Baboon Research Resource (SPFBRR)
Joe H. Simmons · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017 · grant · Lung Cancer Research Foundation Annual Grant Program
2017 – Lung Cancer Research Foundation Annual Grant Program – The University of Texas MD Anderson Cancer Center – Triparna Sen, PhD
Triparna Sen · The University of Texas MD Anderson Cancer Center · funded by Lung Cancer Research Foundation
2017–2020 · research · R01
imaging Radiation-Associated Dysphagia (iRAD)
Clifton David Fuller · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R37
Role of Quaking gene in regulating the niche-independent stemness of glioma stem cells
Jian Hu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Enhancing anti-EGFR Therapeutic Efficacy in Inflammatory Breast Cancer
Naoto T. Ueno · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
BET protein antagonist-based targeted therapy of Mantle Cell Lymphoma
Kapil Bhalla · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Novel regulations of DNA damage repair
Junjie Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Role of response regulator phosphorylation in group A streptococcal pathogenesis
Samuel A Shelburne · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2019 · research · R21
Understanding Uncertainties in Radiomics Studies
Laurence E Court · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2021 · award
Role of Quaking in endocytosis and self-renewal in glioma stem cells
Jian Hu · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
2017–2021 · research · R01
Correcting Dose Calculation Errors in Radiation Oncology
Stephen F Kry · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Role of the Histone Methyltransferase MLL4 in Medulloblastoma
Min Gyu Lee · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2021 · award
Non-Coding RNA Cancer Therapeutics
Anil Sood · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
2017–2022 · research · R01
MSC-Derived Exosomes and MicroRNA in Glioma Therapy
Frederick F Lang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2020 · research · R21
Using hunger training to enhance weight loss and modulate cancer-related biomarkers in women at high risk for breast cancer: a pilot study
Karen M Basen-Engquist · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Enhancing anti-EGFR Therapeutic Efficacy in Inflammatory Breast Cancer
Naoto T. Ueno · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Inhibition of brain metastasis by blocking MAPK12 driver kinase functions
Dihua Yu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Molecular Determinants of Synaptic Plasticity in Chronic Pain
Shao-Rui Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Enhancing Chemoradiation Efficacy through Unbiased Drug Discovery Approaches
Sunil Krishnan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · program · P40
Specific Pathogen Free Baboon Research Resource (SPFBRR) - Administrative Supplement (Epigenetic)
Joe H. Simmons · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · cooperative agreement · U54
University of Texas PDX Development and Trial Center
Funda Meric-Bernstam · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Novel regulations of DNA damage repair
Junjie Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Targeted therapeutics for ovarian cancer and its microenvironment - treatment and theoretical modeling
Gabriel Lopez-Berestein · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
